α-Adrenoceptor and opioid receptor modulation of clonidine-induced antinociception
Author
dc.contributor.author
Sierralta, Fernando
Author
dc.contributor.author
Naquira,
Author
dc.contributor.author
Pinardi,
Author
dc.contributor.author
Miranda, Daniela
Admission date
dc.date.accessioned
2019-01-29T16:00:08Z
Available date
dc.date.available
2019-01-29T16:00:08Z
Publication date
dc.date.issued
1996
Cita de ítem
dc.identifier.citation
British Journal of Pharmacology, Volumen 119, Issue 3, 2018, Pages 551-554
Identifier
dc.identifier.issn
00071188
Identifier
dc.identifier.other
10.1111/j.1476-5381.1996.tb15707.x
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/163044
Abstract
dc.description.abstract
1. The antinociceptive action of clonidine (Clon) and the interactions with α1, α2 adrenoceptor and opioid receptor antagonists was evaluated in mice by use of chemical algesiometric test (acetic acid writhing test). 2. Clon produced a dose-dependent antinociceptive action and the ED50 for intracerebroventricular (i.c.v.) was lower than for intraperitoneal (i.p.) administration (1 ng kg-1 vs 300 ng kg-1). The parallelism of the dose-response curves indicates activation of a common receptor subtype. 3. Systemic administration of prazosin and terazosin displayed antinociceptive activity. Pretreatment with prazosin produced a dual action: i.c.v. Clon effect did not change, and i.p. Clon effect was enhanced. Yohimbine i.c.v. or i.p. did not induce antinonciception, but antagonized Clon-induced activity. These results suggest that α1- and α2-adrenoceptors, either located at the pre- and/or postsynaptic level, are involved in the control of spinal antinociception. 4. Naloxone (NX) and naltre